rocuronium and Muscular-Dystrophy--Facioscapulohumeral

rocuronium has been researched along with Muscular-Dystrophy--Facioscapulohumeral* in 2 studies

Other Studies

2 other study(ies) available for rocuronium and Muscular-Dystrophy--Facioscapulohumeral

Article	Year
[Anesthetic Management of a Patient with Facioscapulohumeral Muscular Dystrophy: Importance of Monitoring Neuromuscular Function at Multiple Sites]. Masui. The Japanese journal of anesthesiology, 2015, Volume: 64, Issue:12 A 39-year-old female with facioscapulohumeral muscular dystrophy (FSHD) was scheduled for thoracoscopic resection of an anterior mediastinal tumor. She had slowly progressive weakness and atrophy in the fascial and shoulder girdle muscles. General anesthesia was induced and maintained with propofol, remifentanil, and fentanyl combined with thoracic paravertebral block. Rocuronium-induced neuromuscular blockade was evaluated with acceleromyography at the corrugator supercilii, masseter, and adductor pollicis muscles. There was no reaction at the atrophic corrugator supercilii muscle in response to train-of-four (TOF) stimulation even before rocuronium administration. In contrast twitch responses at the masseter and adductor pollicis muscles to TOF stimulation could be evoked and the duration of action of rocuronium was found to be similar to that of the normal population. The perioperative course was uneventful. Neuromuscular monitoring sites should be carefully selected in FSHD patients because of possible inability to monitor neuromuscular function at the atrophic muscles. Topics: Adult; Androstanols; Anesthesia, General; Anesthetics; Facial Muscles; Female; Humans; Mediastinal Neoplasms; Muscle, Skeletal; Muscular Dystrophy, Facioscapulohumeral; Neuromuscular Blockade; Neuromuscular Monitoring; Rocuronium	2015
[Rocuronium and sugammadex use for the management of neuromuscular blockade in urgent abdominal surgery in a patient with Landouzy-Dejerine myopathy]. Annales francaises d'anesthesie et de reanimation, 2014, Volume: 33, Issue:11 In patients with neuromuscular diseases, the use of rocuronium in the general anesthesia rapid sequence induction provides safety intubation conditions, but induces a deep and prolonged neuromuscular blockade. We report dose reduction to 0.8mg/kg for a 47-year-old female with Landouzy-Dejerine myopathy. Therefore, less dose of sugammadex was given to reverse the neuromuscular block. Topics: Abdomen; Abdominal Pain; Androstanols; Emergency Medical Services; Female; gamma-Cyclodextrins; Humans; Intestines; Laparotomy; Middle Aged; Muscular Dystrophy, Facioscapulohumeral; Nerve Block; Neuromuscular Nondepolarizing Agents; Peritonitis; Rocuronium; Sugammadex	2014

Article

Year

[Anesthetic Management of a Patient with Facioscapulohumeral Muscular Dystrophy: Importance of Monitoring Neuromuscular Function at Multiple Sites].

Masui. The Japanese journal of anesthesiology, 2015, Volume: 64, Issue:12

A 39-year-old female with facioscapulohumeral muscular dystrophy (FSHD) was scheduled for thoracoscopic resection of an anterior mediastinal tumor. She had slowly progressive weakness and atrophy in the fascial and shoulder girdle muscles. General anesthesia was induced and maintained with propofol, remifentanil, and fentanyl combined with thoracic paravertebral block. Rocuronium-induced neuromuscular blockade was evaluated with acceleromyography at the corrugator supercilii, masseter, and adductor pollicis muscles. There was no reaction at the atrophic corrugator supercilii muscle in response to train-of-four (TOF) stimulation even before rocuronium administration. In contrast twitch responses at the masseter and adductor pollicis muscles to TOF stimulation could be evoked and the duration of action of rocuronium was found to be similar to that of the normal population. The perioperative course was uneventful. Neuromuscular monitoring sites should be carefully selected in FSHD patients because of possible inability to monitor neuromuscular function at the atrophic muscles.

Topics: Adult; Androstanols; Anesthesia, General; Anesthetics; Facial Muscles; Female; Humans; Mediastinal Neoplasms; Muscle, Skeletal; Muscular Dystrophy, Facioscapulohumeral; Neuromuscular Blockade; Neuromuscular Monitoring; Rocuronium

2015

[Rocuronium and sugammadex use for the management of neuromuscular blockade in urgent abdominal surgery in a patient with Landouzy-Dejerine myopathy].

Annales francaises d'anesthesie et de reanimation, 2014, Volume: 33, Issue:11

In patients with neuromuscular diseases, the use of rocuronium in the general anesthesia rapid sequence induction provides safety intubation conditions, but induces a deep and prolonged neuromuscular blockade. We report dose reduction to 0.8mg/kg for a 47-year-old female with Landouzy-Dejerine myopathy. Therefore, less dose of sugammadex was given to reverse the neuromuscular block.

Topics: Abdomen; Abdominal Pain; Androstanols; Emergency Medical Services; Female; gamma-Cyclodextrins; Humans; Intestines; Laparotomy; Middle Aged; Muscular Dystrophy, Facioscapulohumeral; Nerve Block; Neuromuscular Nondepolarizing Agents; Peritonitis; Rocuronium; Sugammadex

2014